Lilly launches Mounjaro pen in India at Rs 14,000 for starting dose, stepping up Novo rivalry
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
16 hours ago
- The Print
‘Must take proactive steps'—PM Modi reiterates concern over obesity crisis in I-Day address
Modi reinforced his previous recommendations to address this, urging families to purchase 10 percent less cooking oil, and reduce its consumption by the same margin on a regular basis. 'When discussing fitness, I am compelled to raise an important concern. Obesity is becoming a significant challenge that every family should take seriously. We must take proactive steps to protect ourselves from it,' the prime minister said. New Delhi: Prime Minister Narendra Modi has once again raised concerns about the issue of obesity, stressing on the need for collective action to tackle the crisis. In his address at Red Fort in Delhi on the occasion of the 79th Independence Day, Modi highlighted expert forecasts indicating that one in every three individuals in the country could become obese in near future. A 2023 survey by the Indian Council of Medical Research (ICMR) and Madras Diabetes Research Foundation (MDRF) had shown that 25.4 crore Indians or 28.6 percent of the population had generalised obesity. This survey had estimated the number of people with abdominal obesity at 351 million, or 39.5 percent of the population. The ICMR-National Institute of Nutrition, in its dietary guidelines last year, had noted that there is rising prevalence of overweight and obesity in several states, adding that 56.4 percent of India's total disease burden is due to unhealthy diets with a major focus on carbohydrates. Obesity, now recognised as a chronic, relapsing disease, is a major risk factor for diabetes, and is found to be linked to over 200 health complications, including hypertension, dyslipidemia or high blood cholesterol, coronary heart disease, some types of cancers and obstructive sleep apnea, among others. The World Health Organization (WHO) defines overweight and obesity in adults using body mass index. Those with a BMI between 25 and 30 kilograms per square metre are considered overweight, while people with a BMI of more than 30 kilograms per square metre are classified as obese. However, according to experts, India has a larger problem of abdominal obesity, characterised by fat deposition around crucial internal organs, but comparatively thinner limbs, which throws its own set of challenges. The growing obesity crisis has prompted Modi, on several occasions this year, to make a pitch for efforts to curb the epidemic. In his monthly radio broadcast in February, he had first called on people to reduce the use of cooking oils commonly found in unhealthy food. He had also previously urged people to adopt an active and healthy lifestyle in order to prevent obesity. This year, India saw the launch of two drugs—Wegovy by Novo Nordisk and Mounjaro by Eli Lilly and Company—that have been global smash hits for years for obesity treatment exclusively. (Edited by Mannat Chugh) Also Read: 82.5 mn Indians were 'obese' in 2022, shows Lancet study. Doctors, nutritionists say 'tip of iceberg'
Time of India
a day ago
- Time of India
How do Chia seeds impact your body? Experts reveal surprising effects of the tiny superfood on heart, gut, and sleep
A Nutrient Powerhouse for the Heart, Gut and Sleep A Natural Ally for Weight Management MORE STORIES FOR YOU ✕ « Back to recommendation stories I don't want to see these stories because They are not relevant to me They disrupt the reading flow Others SUBMIT Easy Ways to Add Them to Your Diet They may be small enough to sprinkle over a smoothie, but chia seeds pack a nutritional punch that could transform your health in ways you might not expect. A recent video by 5 Minute Fitness has broken down what happens when you eat them every day, revealing benefits that go far beyond the hype seen on social media wellness to the 5 Minute Fitness video, chia seeds have been shown to support heart health, improve digestion and even enhance sleep quality. Their high content of tryptophan, an amino acid linked to the production of melatonin, may help regulate the body's sleep-wake same video notes that chia seeds are also rich in calcium and other nutrients essential for strong teeth and bones, while their antibacterial properties can help freshen breath and even aid in the healing of canker some turn to costly weight loss medications such as Ozempic and Mounjaro, chia seeds offer a budget-friendly, side-effect-free alternative. Packed with fibre and protein, they can help you feel full for longer, reducing overall appetite and curbing soluble fibre in chia seeds absorbs water to form a gel-like substance in the stomach, slowing digestion and easing constipation — making them a simple yet effective tool for supporting healthy weight do not need to overhaul your meals to start enjoying chia seeds' benefits. They work well sprinkled over yoghurt, cereal or blended into smoothies. For something more indulgent, you could mix them into chocolate pudding or pair them with peanut butter and banana on in most supermarkets for just a few dollars a pack, chia seeds are an affordable addition that could boost your well-being without disrupting your usual routine.
Time of India
a day ago
- Time of India
One in four US adults with diabetes used a GLP-1 drug last year, survey finds
Bengaluru: More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention said on Thursday. The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly and Ozempic from Novo Nordisk are approved in the United States for treating type 2 diabetes. They are sold as Zepbound and Wegovy, respectively, for weight loss and are being tested for other conditions. Use of the injectable drugs was highest among adults with diabetes aged 50-64 at 33.3%, reflecting the more significant disease burden in this group, the report said. A quarter or 25.3% of adults with diabetes aged 18 to 34 reported using a GLP-1 drug, while the adoption rate was 20.8% among those 65 and older. The data are from a nationally representative annual survey of U.S. adults aged 18 and older that was conducted in person and with follow-up by phone in 2024. In 2024, for the first time, participants in the annual survey who had diabetes were asked if they were using the Lilly or Novo blockbusters or other GLP-1 drugs to lower blood sugar or lose weight. The drugs mimic the activity of a hormone that regulates blood sugar levels, slows digestion and helps people feel full for longer. Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply. Roughly 31% of survey participants who reported using insulin also reported using GLP-1 drugs, as did about 28% of patients who were using oral drugs to control their blood sugar, according to the report, indicating that these treatments are being integrated into combination regimens. Hispanic adults with diabetes had the highest rate of GLP-1 use, at 31.3%, followed by Black non-Hispanic and White non-Hispanic adults, at 26.5% and 26.2%, respectively, the survey found.
